Variables | Survivor (n = 94, 32.9%) | Non-survivor (n = 192, 67.1%) | P value |
---|---|---|---|
Age (year) | 59.6 ± 14.9 | 61.7 ± 14.6 | 0.257 |
Male (%) | 61 (65.6) | 119 (62.0) | 0.553 |
MAP (mmHg) | 81.7 ± 13.9 | 73.1 ± 12.8 | <0.001 |
APACHE II score | 24.0 ± 7.5 | 28.1 ± 7.3 | <0.001 |
SOFA score | 10.8 ± 3.7 | 14.2 ± 3.1 | <0.001 |
Charlson comorbidity score | 12.9 ± 2.3 | 13.1 ± 2.0 | 0.347 |
RIFLE criteria (%)a | |||
 Risk | 48 (51.1) | 81 (42.2) | 0.345 |
 Injury | 23 (24.5) | 59 (30.7) |  |
 Failure | 23 (24.5) | 52 (27.1) |  |
Comorbid diseases (%) | |||
 Hypertension | 46 (48.9) | 65 (33.9) | 0.014 |
 Diabetes mellitus | 40 (42.6) | 58 (30.2) | 0.039 |
Biochemical data | |||
 DNI (%) | 3.95 (2.35–9.10) | 8.35 (3.23–24.73) | <0.001b |
 Hemoglobin (g/dL) | 10.5 ± 8.7 | 9.2 ± 2.2 | 0.063 |
 WBC (103/mm3) | 13.9 (8.9–20.3) | 10.6 (4.0–17.5) | 0.009b |
 Platelet (103/ mm3) | 114 (57–204) | 80 (44–129) | 0.002b |
 eGFR (mL/min/1.73 m2) | 76.7 ± 32.5 | 80.4 ± 29.2 | 0.404 |
 Cholesterol (mg/dL) | 98.1 ± 50.5 | 90.9 ± 46.5 | 0.271 |
 Albumin (g/dL) | 2.8 ± 0.7 | 2.6 ± 0.6 | 0.013 |
 hs-CRP (mg/L) | 106.0 (49.7–205.5) | 102.6 (26.7–198.0) | 0.581b |
 Total bilirubin (mg/dL) | 1.4 (0.6–3.0) | 1.9 (0.7–4.5) | 0.101b |
 PT (INR) | 1.5 ± 0.6 | 1.7 ± 0.8 | 0.007 |
 aPTT (sec) | 40.4 ± 14.6 | 53.1 ± 31.9 | <0.001 |